The Relapsing-Remitting Multiple Sclerosis (MS) patients research has revealed that the matrix metalloproteinase-2 level in cerebrospinal fluid which is higher then 30 ng/ml during the relapse and/or remission period increases repeated relapse risk during 2 years term by 2.8 times. The rapid MS progressing is associated with the high level of adhesion molecule (sPECAM) in cerebrospinal fluid.

+More

relapse matrix metalloproteinase2 adhesion molecule specam

I. V. Smagina,S. A. Yelchaninova,A. V. Popovtseva,Yu. N. Ignatova,A. O. Gridina,A. S. Fedyanin,.Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing. 9 (4),.

I. V. Smagina,S. A. Yelchaninova,A. V. Popovtseva,Yu. N. Ignatova,A. O. Gridina,A. S. Fedyanin,"Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing" 9

I. V. Smagina,S. A. Yelchaninova,A. V. Popovtseva,Yu. N. Ignatova,A. O. Gridina,A. S. Fedyanin,"Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing"